SEC Form 4 · accession 0001022079-17-000009
QUEST DIAGNOSTICS INC · DGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael E Prevoznik
Officer — SVP & General Counsel
Period of report
Feb 2, 2017
Accepted (ET)
Feb 6, 2017 · 4:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001022079
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 2, 2017 | M | 30,000 | $51.20 | A | 71,918 | D | |
| Common StockF1 | Feb 2, 2017 | S | 30,000 | $92.395 | D | 41,918 | D | |
| Common Stock | Feb 2, 2017 | M | 15,000 | $55.65 | A | 56,918 | D | |
| Common StockF2,F3 | Feb 2, 2017 | S | 15,000 | $92.383 | D | 41,986 | D | |
| Common StockF4 | holding | — | — | — | 4,809 | I | 401(k)/SDCP |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F5 | $51.20 | Feb 2, 2017 | M | 30,000 | D | — | Feb 11, 2019 | Common Stock | 30,000 | 0 | D |
| Stock Options (Right to Buy)F5 | $55.65 | Feb 2, 2017 | M | 15,000 | D | — | Feb 10, 2020 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $92.08 to $92.79. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2This transaction was executed in multiple trades at prices ranging from $92.06 to $92.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F3The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.
- F4These underlying shares were acquired on a periodic basis by the trustee of the Company's tax qualified Profit Sharing (401(k)) and/or Supplemental Deferred Compensation Plan. The information was obtained from the plan administrator as of a current date. The number of shares is based on the account balance of the Company stock fund under each Plan (which includes some money market instruments) divided by the market price of the Company's stock as of that date.
- F5The options vested in three equal annual installments beginning on the first annual anniversary of the grant date.